Wenxin Xu
0000-0002-8450-2037
Publication & Citation Trends
Publications
295 total
Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitors PDF
Cited by 111
OpenAlex
Progressive immune dysfunction with advancing disease stage in renal cell carcinoma PDF
Cited by 493
OpenAlex
Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19 PDF
Cited by 184
OpenAlex
Clinical Activity and Safety of Cabozantinib for Brain Metastases in Patients With Renal Cell Carcinoma PDF
Cited by 95
OpenAlex
Natural Language Processing to Ascertain Cancer Outcomes From Medical Oncologist Notes PDF
Cited by 84
OpenAlex
IL-15 superagonist/IL-15RαSushi-Fc fusion complex (IL-15SA/IL-15RαSu-Fc; ALT-803) markedly enhances specific subpopulations of NK and memory CD8+ T cells, and mediates potent anti-tumor activity against murine breast and colon carcinomas PDF
Cited by 156
OpenAlex
Research Topics
Cancer Immunotherapy and Biomarkers
(155)
Renal cell carcinoma treatment
(118)
Cancer Diagnosis and Treatment
(59)
Systemic Sclerosis and Related Diseases
(52)
Bladder and Urothelial Cancer Treatments
(41)
Affiliations
Boston University
Hebei Medical University
Brigham and Women's Hospital
Morgan Stanley Children's Hospital
City Of Hope National Medical Center